[go: up one dir, main page]

NO20042884L - Fremstilling av trans-kondenserte 3,3a,8,12b-tetrahydro-2H-dibenco[3,4,:6,7]cykloheptal[1.2.b]furanderivater - Google Patents

Fremstilling av trans-kondenserte 3,3a,8,12b-tetrahydro-2H-dibenco[3,4,:6,7]cykloheptal[1.2.b]furanderivater

Info

Publication number
NO20042884L
NO20042884L NO20042884A NO20042884A NO20042884L NO 20042884 L NO20042884 L NO 20042884L NO 20042884 A NO20042884 A NO 20042884A NO 20042884 A NO20042884 A NO 20042884A NO 20042884 L NO20042884 L NO 20042884L
Authority
NO
Norway
Prior art keywords
trans
preparation
dibenco
cycloheptal
tetrahydro
Prior art date
Application number
NO20042884A
Other languages
English (en)
Norwegian (no)
Inventor
Bart Petrus Anna Maria Medaer
Hua Mao
Yolande Lydia Lang
Tomasz Kozlecki
Frans Josef Cornel Compernolle
Georges Joseph Cornel Hoornaer
Thierry Brossette
Michel Joseph Mauric Giillaume
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20042884L publication Critical patent/NO20042884L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20042884A 2001-12-07 2004-07-07 Fremstilling av trans-kondenserte 3,3a,8,12b-tetrahydro-2H-dibenco[3,4,:6,7]cykloheptal[1.2.b]furanderivater NO20042884L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01204961 2001-12-07
PCT/EP2002/013560 WO2003048146A1 (fr) 2001-12-07 2002-12-02 Preparation de derives de 3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furane a fusion trans

Publications (1)

Publication Number Publication Date
NO20042884L true NO20042884L (no) 2004-07-07

Family

ID=8181460

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042884A NO20042884L (no) 2001-12-07 2004-07-07 Fremstilling av trans-kondenserte 3,3a,8,12b-tetrahydro-2H-dibenco[3,4,:6,7]cykloheptal[1.2.b]furanderivater

Country Status (20)

Country Link
US (2) US6998494B2 (fr)
EP (1) EP1456193B1 (fr)
JP (1) JP4516752B2 (fr)
KR (1) KR20050044329A (fr)
CN (1) CN1293066C (fr)
AT (1) ATE294168T1 (fr)
AU (1) AU2002342926B2 (fr)
BR (1) BR0214068A (fr)
CA (1) CA2468038C (fr)
DE (1) DE60203937T2 (fr)
ES (1) ES2242076T3 (fr)
HR (1) HRP20040490A2 (fr)
HU (1) HUP0402152A3 (fr)
IL (1) IL162349A0 (fr)
MX (1) MXPA04005400A (fr)
NO (1) NO20042884L (fr)
NZ (1) NZ532806A (fr)
PL (1) PL369585A1 (fr)
WO (1) WO2003048146A1 (fr)
ZA (1) ZA200404394B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL162349A0 (en) * 2001-12-07 2005-11-20 Janssen Pharmaceutica Nv Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6,7Ücyclohepta Ä1,2-bÜfuran derivatives
WO2005013969A1 (fr) * 2003-07-15 2005-02-17 Janssen Pharmaceutica N.V. Agent antipsychotique a proprietes favorisant la socialisation
PT1761514E (pt) * 2004-06-14 2008-10-28 Janssen Pharmaceutica Nv Novos derivados de tetra-hidrofurano tetracíclicos
US7470809B2 (en) * 2004-08-31 2008-12-30 Janssen Pharmaceutica N.V. Process for the production of [2-(4-fluoro-benzyl)-phenyl]-acetic acid
AU2005313325C1 (en) 2004-12-07 2011-11-10 Janssen Pharmaceutica N.V. Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives
MX2007009092A (es) 2005-01-27 2007-09-12 Janssen Pharmaceutica Nv Derivados de tetrahidrofurano tetraciclicos heterociclicos como inhibidores de 5ht2 en el tratamiento de trastornos del sistema nervioso central.
AU2006259020C1 (en) 2005-06-17 2012-01-19 Janssen Pharmaceutica N.V. Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI0892793T1 (en) * 1996-04-12 2003-10-31 Janssen Pharmaceutica N.V. Substituted tetracyclic tetrahydrofuran derivatives
UA52778C2 (uk) * 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
UA79248C2 (en) * 2001-11-09 2007-06-11 Janssen Pharmaceutica Nv Mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
EP1463722A2 (fr) * 2001-12-07 2004-10-06 Janssen Pharmaceutica N.V. PREPARATION DE DERIVES DE 3,3a,8,12b-TETRAHYDRO-2H-DIBENZO[3,4:6,7]CYCLOHEPTA[1,2-b]FURANES FUSIONNES EN CIS
IL162349A0 (en) * 2001-12-07 2005-11-20 Janssen Pharmaceutica Nv Preparation of trans-fused 3,3a,8,12b-tetrahydro-2h-dibenzo Ä3,4:6,7Ücyclohepta Ä1,2-bÜfuran derivatives

Also Published As

Publication number Publication date
ES2242076T3 (es) 2005-11-01
BR0214068A (pt) 2004-10-13
CA2468038C (fr) 2011-04-26
ATE294168T1 (de) 2005-05-15
HK1076461A1 (en) 2006-01-20
JP4516752B2 (ja) 2010-08-04
CN1602306A (zh) 2005-03-30
PL369585A1 (en) 2005-05-02
IL162349A0 (en) 2005-11-20
AU2002342926B2 (en) 2009-02-26
HRP20040490A2 (en) 2004-10-31
ZA200404394B (en) 2005-09-05
US6998494B2 (en) 2006-02-14
HUP0402152A3 (en) 2007-03-28
AU2002342926A1 (en) 2003-06-17
CA2468038A1 (fr) 2003-06-12
JP2005511691A (ja) 2005-04-28
HUP0402152A2 (hu) 2005-02-28
US20050228043A1 (en) 2005-10-13
KR20050044329A (ko) 2005-05-12
NZ532806A (en) 2006-01-27
EP1456193B1 (fr) 2005-04-27
DE60203937T2 (de) 2006-05-11
EP1456193A1 (fr) 2004-09-15
WO2003048146A1 (fr) 2003-06-12
US20050014820A1 (en) 2005-01-20
DE60203937D1 (de) 2005-06-02
CN1293066C (zh) 2007-01-03
MXPA04005400A (es) 2004-10-11

Similar Documents

Publication Publication Date Title
NZ522568A (en) Substituted bicyclic derivatives for the treatment of abnormal cell growth
HUP9701048A2 (hu) Új eljárás sildenafil előállítására és a felhasznált új köztitermékek
AU2001232287A1 (en) Novel pyrazine derivatives or salts thereof, pharmaceutical compositions containing the derivatives or the salts and intermediates for the preparation of both
AUPR213700A0 (en) Antiviral agents
SE0102616D0 (sv) Novel compounds
YU70901A (sh) Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
YU94103A (sh) Novi derivati sulfonske kiseline
MA29617B1 (fr) Derives de n-(arylalkyl)-1h-pyrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique.
DK0915894T3 (da) Nukleotidanaloger
NO20042884L (no) Fremstilling av trans-kondenserte 3,3a,8,12b-tetrahydro-2H-dibenco[3,4,:6,7]cykloheptal[1.2.b]furanderivater
CA2397270A1 (fr) Procede de preparation de 5-cyanophthalide
MXPA04005399A (es) Preparacion de derivados cis-fusionados de 3, 3a, 8, 12b-tetrahidro-2h-dibenzo [3,4:6,7]ciclohepta[1,2-b]furano.
PT1204658E (pt) Agonistas benzofurilpiperazina de serotonina
WO2001056992A3 (fr) Derives de dibenzo [b,f]azepine et leur preparation
ATE284882T1 (de) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
ATE307103T1 (de) Hyperforin-derivate, ihre verwendung sowie diese enthaltende zubereitungen
WO2004065360A3 (fr) Nouveaux derives de piperazine et leur utilisation comme intermediaires de synthese
BG106846A (en) Novel heteroaryl derivatives, their preparation and use
EE200300058A (et) Imidaso[1,2-c] [2,3] bensodiasepiinide valmistamismeetod ja vaheühendid nende valmistamisel
DE69811382D1 (de) Carbapenemderivate und herstellungsverfahren dafür
EP1241167A4 (fr) Derives de 3-ethyl-, 3-propyl-, ou 3-butyl-chromane et -thiochromane
ES2082202T3 (es) Derivados de biciclo(3.3.0)octano, procedimiento para su preparacion y su utilizacion farmaceutica.
FI104078B (fi) Menetelmä terapeuttisesti käyttökelpoisten (3-(1-piperatsinyyli)tieno£2,3-b|- ja -£2,3-c|pyridiinijohdannaisten valmistamiseksi
BG106971A (en) Method for the preparation of 5-cyanophthalide
DK1490391T3 (da) 11beta-langkædet substituerede 19-nor-17alfa-pregna-1,3,5(10)-trien-17beta-oler med en 21,2alfa-lactonring

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application